122
“This device has the potential to drastically improve the lives of people with Tourette syndrome, who often find it difficult to control their tics, by allowing them better control of their tics on demand,” he said Jackson. A commercial device and app should be available within the next three years. The was financed Research by the UK charity Tourettes Action, the NIHR Nottingham Biomedical Research Center and as well as by Neurotherapeutics.